A nurse is assessing a patient who received a blood transfusion 2 hours ago.
The nurse notes that the patient has developed dyspnea, orthopnea, tachypnea, and crackles on lung auscultation.
Which type of transfusion reaction should the nurse suspect?

Choice A rationale:

Fever is a potential sign of a delayed transfusion reaction.

Delayed transfusion reactions can occur several days after a blood transfusion and may present with fever as a symptom.

This can be indicative of hemolysis or an immune response to the transfused blood.

Choice C rationale:

Jaundice is another sign that the nurse should monitor for delayed transfusion reactions.

Jaundice can be a result of hemolysis, where the red blood cells are destroyed, leading to an increase in bilirubin levels in the bloodstream.

Choice B rationale:

Increased urine output is not typically associated with delayed transfusion reactions.

Delayed reactions are more likely to manifest as fever, jaundice, or other signs of hemolysis.

Choice D rationale:

Hypertension is not a common sign of delayed transfusion reactions.

These reactions are more likely to present with symptoms related to the destruction of red blood cells, such as fever and jaundice.

Choice E rationale:

Decreased oxygen saturation is not a typical sign of delayed transfusion reactions.

It is important to monitor oxygen saturation during a blood transfusion, but this is more relevant to immediate transfusion reactions, such as transfusion-related acute lung injury (TRALI)

Choice A rationale:

Lactated Ringer's solution is a volume expander, not a therapy for improving oxygen-carrying capacity.

It can increase blood volume but does not address the underlying cause of anemia or hypoxia.

Choice B rationale:

Hemostatic agents like protamine sulfate are used to reverse the anticoagulant effects of heparin.

They are not indicated for improving oxygen-carrying capacity in anemic patients.

Choice C rationale:

Oxygen therapy delivered through a nasal cannula or mask is indeed a therapy to enhance oxygen-carrying capacity.

It provides supplemental oxygen to improve oxygen saturation in the blood, which can alleviate hypoxia in anemic patients.

Choice D rationale:

Erythropoietin injections can stimulate the production of red blood cells in the bone marrow.

This therapy can increase the patient's hemoglobin levels and improve oxygen-carrying capacity, making it a suitable recommendation for a patient with hypoxia due to anemia.

For , choices A, C, and D are correct as they are examples of volume expanders that can increase blood volume and circulation without adding blood cells.

For , choice C is correct as hemostatic agents like vitamin K or tranexamic acid can promote clotting and stop bleeding in a patient with a bleeding disorder.

For , choice D is correct as erythropoietin injections can stimulate the production of red blood cells and help alleviate hypoxia in a patient with anemia.